ETF Components for EWL - iShares MSCI Switzerland Capped Index Fund


Below is a list of stocks held by this ETF. We only list holdings in the same market. If this is a global ETF, there may be additional components other than those listed here.

Holdings

Symbol Grade Price % Change Allocation
NVS F 0.89 11.91
ABBV C 0.97 4.66
LOGI C 1.03 1.05

Recent News for iShares MSCI Switzerland Capped Index Fund & its Holdings

Date Stock Title
Mar 28 ABBV Aldeyra gains on plans for AbbVie-partnered eye disease drug
Mar 28 ABBV Pharma Stock Roundup: ABBV & NVO's New M&As, FDA Nod to JNJ & MRK PAH Drugs
Mar 28 NVS Investors Heavily Search Novartis AG (NVS): Here is What You Need to Know
Mar 28 ABBV Should WisdomTree U.S. High Dividend ETF (DHS) Be on Your Investing Radar?
Mar 27 NVS Mesoblast (MESO) to File Pediatric GVHD Drug BLA, Stock Up
Mar 27 ABBV AbbVie: An Undervalued Giant
Mar 27 LOGI Logitech Unveils Signature Slim Keyboard and Combo to Seamlessly Flow Between Work and Life at the Desk
Mar 26 ABBV AbbVie (ABBV) to Buy Landos to Strengthen Autoimmune Portfolio
Mar 26 ABBV 20 Cloudiest Cities in the U.S., Ranked
Mar 26 LOGI Logitech International (VTX:LOGN) stock performs better than its underlying earnings growth over last five years
Mar 25 NVS Novartis (NVS) Declines More Than Market: Some Information for Investors
Mar 25 ABBV AbbVie (ABBV) Advances While Market Declines: Some Information for Investors
Mar 25 ABBV Why Is Ulcerative Colitis-Focused Landos Biopharma Stock Trading Higher On Monday?
Mar 25 NVS 30 Countries with Highest Proportion of Older Adults
Mar 25 ABBV 30 Countries with Highest Proportion of Older Adults
Mar 25 ABBV Why AbbVie (ABBV) is a Great Dividend Stock Right Now
Mar 25 ABBV Landos shares rocket 170% on AbbVie takeover deal
Mar 25 ABBV Allergan Aesthetics Launches "Moving the Needle on Ethics" to Elevate the Conversation Around Ethics in Aesthetics
Mar 25 LOGI Zacks.com featured highlights include Meta Platforms, Deckers Outdoor, Vimeo and Logitech International
Mar 25 ABBV AbbVie to bolster immunity illness drug pipeline with Landos deal
The investment seeks investment results that correspond generally to the price and yield performance, before fees and expenses, of the MSCI Switzerland 25/50 Index. The fund will at all times invest at least 80% of its assets in the securities of its underlying index and in depositary receipts ("DRs") representing securities in its underlying index. The MSCI Switzerland 25/50 Index consists of stocks traded primarily on the Zurich Stock Exchange. A capping methodology is applied that limits the weight of any single component to a maximum of 25% of the MSCI Switzerland 25/50 Index. The fund is non-diversified.
Exchange Traded Fund ETF Exchange Traded Funds MSCI EAFE
Back to the Main EWL Page...